Stamford, CT -- (SBWIRE) -- 01/24/2014 -- Wall Street Pennies is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Provectus Pharmaceuticals, Inc. (OTCMKTS:PVCT), Hemispherx BioPharma, Inc (NYSEMKT:HEB), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), BlackBerry Ltd (NASDAQ:BBRY).
Provectus Pharmaceuticals, Inc. (OTCMKTS:PVCT) opened its last trade at the price of $5.60. Its closing price was $1.87 after losing -64.18% for the day. The company traded with the total volume of 30.51 million shares, while its average trading volume remained 2.57 million shares. The beta of this stock stands at 0.66. Provectus Pharmaceuticals, Inc., a development-stage pharmaceutical company, engages in developing pharmaceuticals for oncology and dermatology indications. The company’s product line includes PV-10, a Phase II study completed drug candidate for metastatic melanoma, a Phase I study completed candidate for breast cancer, and a Phase I protocol expansion candidate for liver metastasis;
Has PVCT Found The Bottom and Ready To Move Up? Find Out Here
Hemispherx BioPharma, Inc (NYSEMKT:HEB) percentage change surged 19.57% to close at $0.550 with the total traded volume of 17.06 million shares, along with average volume of 4.59 million shares. The 52 week range of the stock remained $0.18 - $0.55, while its day lowest price was $0.49. The share price hit the day highest price of $0.55. Hemispherx Biopharma, Inc., a specialty pharmaceutical company, engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders.
Will HEB Continue To Move Higher? Find Out Here
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) traded on volume of 57.25 million shares in the last session against average volume of 29.37 million shares. The company started its trading session with the price of $7.28 and closed at $7.52 by scoring +12.07%. ARIAD Pharmaceuticals, Inc., an oncology company, focuses on the discovery, development, and commercialization of medicines for cancer patients. The company focuses on commercializing Iclusig (ponatinib), a cancer medicine; and developing additional molecularly targeted therapies to treat patients with blood cancers and solid tumors.
Why Should Investors Buy ARIA After The Recent Gain? Just Go Here and Find Out
BlackBerry Ltd (NASDAQ:BBRY) started its last trading session with the price of $10.68 and closed at $10.45 by scoring -3.06%. The stock traded with total volume of 37.24 million shares, while the average trading volume remained 33.40 million shares. The beta value of this stock stands at 1.40. Day range for the stock was $9.88 - $10.70. BlackBerry Limited engages in the design, manufacture, and marketing of wireless solutions worldwide. It provides platforms and solutions for access to email, voice, instant messaging, short message service, Internet and Intranet-based applications, and browsing through the development of integrated hardware, software, and services.
Will BBRY Get Buyers Even After The Recent Rally? Find Out Here
About Wall Street Pennies:
Wall Street Pennies is always penetrating the market every day for enormous penny stock runs before they happen in order to assist its customers. Our Penny Stock Newsletter also offers free market strategies and analysis from one of the most experienced and well-respected chartists in the penny stock industry.
Carriage Consulting Group, www.wallstreetpennies.com,, their Members, officers, directors, employees, affiliates, or any other related person(s) (collectively, “www.wallstreetpennies.com,”) are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. Wall Street Pennies as defined are neither licensed nor qualified to provide investment advice and you are specifically and adamantly advised not to rely upon anything said/posted/communicated/implied or expressed by www.wallstreetpennies.com, as defined.
Read full Disclaimer at: http://wallstreetpennies.com/financial-disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)